With the recent reauthorization of the Small Business Innovation Research (SBIR) program, now is a critical time for life science companies to revisit non-dilutive funding opportunities. Applying for grants can be an overwhelming process, let us make it easier for you!
On May 19, join us for a virtual workshop where Natalie Rudolph and Elizabeth Cross Nichol will share practical insights into SBIR funding for life science companies. They’ll begin with the basics of the SBIR/STTR program and key updates following reauthorization, including agency types and missions, grants versus contracts, project phases, and the program’s increased emphasis on commercialization. Following its recent reauthorization, SBIR continues to offer highly competitive, non-dilutive funding to help startups advance technology and IP without giving up equity.
Participants will gain guidance on writing compelling, persuasive applications that stand out in a competitive funding landscape. If you’re looking to build the knowledge to pursue seed funding opportunities and navigate reauthorization with confidence, this session is for you.